A University of Minnesota Twin Cities team has, for the first time, developed a new tool to predict and customize the rate of a specific kind of DNA editing called "site-specific recombination." The research paves the way ...
Biotechnology
Jul 20, 2022
0
68
Cancer immunotherapy is a treatment modality against tumor growth and metastasis via stimulating host immune responses. Phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is a less invasive ...
Bio & Medicine
May 30, 2022
0
14
Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small molecule that blocked a key pathway in brain tumors. But there was a problem: How to get the inhibitor through the ...
Bio & Medicine
May 26, 2022
0
144
Antibiotic resistance represents a major public health challenge, and is associated with a high mortality rate. While bacteriophages—viruses that kill bacteria—could be a solution for fighting antibiotic-resistant pathogens, ...
Cell & Microbiology
May 17, 2022
0
61
Our animal companions bring us joy and love us unconditionally. There is no question that our pet dogs and cats play an important role in our lives as companions.
Veterinary medicine
Mar 30, 2022
0
4
New research has moved a step closer to harnessing viruses to fight bacterial infection, reducing the threat of antibiotic resistance.
Cell & Microbiology
Dec 20, 2021
0
101
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients ...
Bio & Medicine
Jul 14, 2021
0
10
A Mason Engineering researcher has discovered that artificial microswimmers accumulate where their speed is minimized, an idea that could have implications for improving the efficacy of targeted cancer therapy.
Cell & Microbiology
Feb 26, 2021
0
6
Adeno-associated viruses (AAVs) have become promising vehicles for delivering gene therapies to defective tissues in the human body because they are non-pathogenic and can transfer therapeutic DNA into target cells. However, ...
Biotechnology
Feb 11, 2021
0
90
WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19.
Bio & Medicine
Nov 24, 2020
0
9
